Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEC14L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KTN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDHA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESYT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF101 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3J - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERMN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDELR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJB9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRR5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DPB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNORA29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGCC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM63B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on